Investor Investigation over Takeover of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN)
June 23, 2017 at 12:30 PM EDT
San Diego, CA -- (SBWIRE) -- 06/23/2017 -- An investigation on behalf of investors, who currently hold shares of SciClone Pharmaceuticals, Inc. (NASDAQ:SCLN), was announced concerning whether the takeover of SciClone Pharmaceuticals, Inc. for $11.18 per share is unfair to NASDAQ:SCLN stockholders.
